Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 30.09 | 37.05 |
PEG Ratio (TTM) | -3.11 | 11.98 |
P/S Ratio (TTM) | 3.63 | 14.61 |
P/B Ratio (TTM) | 4.55 | 18.78 |
P/FCF Ratio (TTM) | 27.69 | 42.97 |
Price to 5YR AVG Earnings Ratio | N/A | 32.96 |
Price to 5YR AVG FCF Ratio | N/A | 63.36 |
Profitability (35%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.46% | 12.20% |
ROE (TTM) | 15.38% | -7.48% |
Net Profit Margin (TTM) | 11.25% | 24.97% |
ROIC 5YR AVG | N/A | 4.50% |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 15.21% | -2,896.33% | N/A |
Revenue | 3.79% | 22.63% | N/A |
Net Income | 14.50% | -1,396.73% | N/A |
Cash Flow | -3.22% | 44.35% | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.09 | 1.43 |
Quick Ratio (TTM) | 1.09 | 1.41 |
D/E Ratio (TTM) | 0.06 | 1.24 |
Interest Coverage (TTM) | 1.40 | 35.48 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 0.38 | 9.32 |
LTL to 5YR AVG FCF | N/A | 5.27 |
Shares Outstanding Growth 5YR AVG | N/A | 0.66% |